Viewing data from:

FALMINA

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A090721 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Falmina (2023)

Total Spending

$60K

Total Claims

2,225

Beneficiaries

439

Avg Cost/Unit

$0.56

Spending Trend

$72K(2019)→$86K(2020)→$73K(2021)→$62K(2022)→$60K(2023)

YoY Change:-5.6%

5yr CAGR:-1.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;0.1MG

AB1

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 28, 2012

No patent or exclusivity listings for this strength.